Psa is measured by, Endocrine Care

Fenomenul de bounce Psa is measured by dupČ brahiterapia prin implant permanent cu I în cancerul de prostată localizat - factori de predicţie clinici şi dozimetrici.

Source: Romanian Journal of Urology. Dec, Vol. Author s : Hăineală, B. Guler; Sinescu, I. Abstract: Introduction and Objectives: The purpose of the study is to evaluate the incidence, time of occurrence and magnitude of PSA bounce phenomenon BP after permanent prostate implant with I, clinical and dosimetric factors favoring the occurrence of this phenomenon and its impact on biochemical relapse. Material and Methods: Between October - July were treated with permanent prostate implant with I a total of patients with prostate cancer, alone in stage T1c-T2a.

PSA bounce is defined as a temporary increase in PSA value followed by a consecutive decrease recorded with the same value before the increase or a lower value. PSA bounce phenomenon was recorded in 31 patients Results: The average magnitude's bounce was 1.

Share this article

Mean PSA at 12 months for patients on monotherapy who did not show bounce phenomenon was 0. For patients who showed no BP average D90 was Initial PSA values, Gleason score, preoperative prostate volume did not affect this process.

Conclusions: PSA bounce is not a rare phenomenon after prostate brachytherapy and should be always considered whenever we have a patient with rising PSA after implant, especially when the perioud of time that has passed since the procedure is not long.

It occurs more frequently in younger patients and is not related to preoperative clinical and dosimetry factors.

So your PSA number is high...

Copyright of Romanian Journal of Urology is the property of Romanian Journal of Urology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.

This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.

Vanzarile Grupului PSA crestere pentru al treilea an consecutiv În cadrul execuţiei planului strategic de creştere rentabilă «Push to Pass», Grupul PSA a inițiat înstartul unei ofensive mondiale de produs, care prevede de lansări regionale până în anultoate rezultatele acestei acțiuni dovedindu-se succese comerciale pe segmentele lor de piaţă. Prostatita incurabila în 30 de ţări, noul SUV continuă să devină din ce în ce mai cunoscut la nivel global și în primul trimestru din — în Franţa, modelul fiind deja lider al segmentului C-SUV, în intervalul ultimelor trei luni ale anului trecut. În afara lansărilor iniţiate în cursul anului E-Mehari, noul Jumpy, SpaceTourer, noul C3dinamica mărcii este, în special, susţinută de C4 Picasso, referinţă a monovolumelor reînnoite în septembrie de vehiculedar de asemenea și de succesul confirmat de Berlingo, a doua cea mai vândută utilitară din Europa. Marca DS continuă dezvoltarea reţelei sale dedicate cu puncte de vânzare şi saloane DS cât şi primul Urban Store DS, situat în prestigiosul centru comercial din Westfield, la Psa is measured by, inaugurat pe 1 decembrie

Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use. However, remote access to EBSCO's databases from lupta împotriva prostatitei cronice institutions is not allowed if the purpose of the use is for commercial gain psa is measured by cost reduction or avoidance for a non-subscribing institution.